Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Burkitt Lymphoma 1

Interventions

Cyclophosphamide 66Rituximab 43fludarabine phosphate 37Methotrexate 36Whole-Body Irradiation 34Peripheral Blood Stem Cell Transplantation 34Vincristine 33Etoposide 32Cytarabine 29Mycophenolic Acid 28Tacrolimus 23Busulfan 23Prednisone 22Doxorubicin 22Filgrastim 21merphos 20Dexamethasone 20Cyclosporine 19Melphalan 18Calcium Dobesilate 18Granulocyte Colony-Stimulating Factor 17Antilymphocyte Serum 17Radiotherapy 16Leucovorin 15dexamethasone acetate 14dexamethasone 21-phosphate 14auricularum 13prednylidene 12deltacortene 12azathiopurine 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Burkitt Lymphoma × calaspargase pegol × Clear all
NCT00671034 2021-04-27

Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 3 Completed
166 enrolled 18 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡